🇺🇸 FDA
Patent

US 6281196

Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin

expired A61PA61P35/00

Quick answer

US patent 6281196 (Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin) held by THE ARIZONA BOARD OF REGENTS expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE ARIZONA BOARD OF REGENTS
Grant date
Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00